GL1X · GenesisL1 explorer

MolNFT v1 · #149225 · protein

Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP18

6FU5 · Receptor-interacting SERINE/THREONINE-protein kinase 2: “Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP18”. X-ray diffraction, 1 ligand (E7N), 8 pockets (best druggability 0.83). MolNFT v1 #149225…

PDB
6FU5
Type
protein
Length
568 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Receptor-interacting SERINE/THREONINE-protein kinase 2
EC
2.7.11.1, 2.7.10.2
UniProt
O43353
Ligands
E7N
Pockets
8 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReceptor-interacting SERINE/THREONINE-protein kinase 2 (EC 2.7.11.1, 2.7.10.2)protein28241% helix, 17% strandO43353
BReceptor-interacting SERINE/THREONINE-protein kinase 2 (EC 2.7.11.1, 2.7.10.2)protein28640% helix, 16% strandO43353

Ligands and binding sites

  • E7N · ~{N}-[5-[2-azanyl-5-(4-piperazin-1-ylphenyl)pyridin-3-yl]-2-methoxy-phenyl]propane-1-sulfonamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110950.830.8480empty
22760.690.8431E7N
33020.680.8329E7N
41320.480.7829empty
51010.380.7516empty

Interfaces

1 interface between chains.

  • A–B · 2042 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 6FU5 · Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP18 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.